Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
SJMClass II

Quantitative Hepatitis B Surface Antigen

21 CFR 866.3177 / Microbiology

Classification record

Product code
SJM
Device name
Quantitative Hepatitis B Surface Antigen
FDA definition
A quantitative hepatitis B virus (HBV) surface antigen (HBsAg) test is an in vitro diagnostic device intended for prescription use for the quantitative determination of HBsAg in human serum, plasma, or other matrices specimens from individuals with HBV infection as an aid in the management of HBV-infected individuals including identifying patients who may benefit from treatment with appropriate antiviral therapies in accordance with the approved therapeutic product labeling.
Regulation
21 CFR 866.3177
Device class
Class II
Review panel
Microbiology
Submission type
510(k)
Implant
No
Life sustaining or supporting
No
GMP exempt
No
Third party review eligible
No
Ingested clearances
1
Ingested recalls
0

Clearances, product code SJM

By decision year
1 clearance under product code SJM with a decision year between 2026 and 2026, 2026 the highest year at 1.
Show the numbers
510(k) clearances under FDA product code SJM by decision year
YearClearances
20261

Applicants with the most clearances

Product code SJM
Applicants holding the most 510(k) clearances under product code SJM
ApplicantClearances
Roche Diagnostics1

Companies listing this code with FDA

Companies whose registered establishments list this code